Neoadjuvant camrelizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma: a single-arm, phase 2 trial
乔垣结衣
18天前
48
20
已完结
1. 系统已在2025-05-02 15:48:56对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s10120-025-01606-w
文献链接: https://link.springer.com/10.1007/s10120-025-01606-w
其他信息:
出版社: Springer Science and Business Media LLC
作者: Yijie Ma; Zhi Li; Chen Wei; Jian Zhang; Qiang Fu; Zhandong Zhang; Chuang Shang; Jinbang Wang; Xiangbin Wan; Bin Zhang; Yongchao Zhang; Jing Li; He Zhang; Liangyu Bie; Qingxin Xia; Suxia Luo; Ning Li
全文下载地址: https://link.springer.com/content/pdf/10.1007/s10120-025-01606-w.pdf
